Hostname: page-component-77f85d65b8-pztms Total loading time: 0 Render date: 2026-03-29T23:16:21.878Z Has data issue: false hasContentIssue false

The pathogenesis of bornaviral diseases in mammals

Published online by Cambridge University Press:  23 May 2016

Ian Tizard*
Affiliation:
Department of Veterinary Pathobiology and the Schubot Exotic Bird Health Center, Texas A&M University, College of Veterinary Medicine and Biomedical Sciences, College Station, Texas 77843, USA
Judith Ball
Affiliation:
Department of Veterinary Pathobiology and the Schubot Exotic Bird Health Center, Texas A&M University, College of Veterinary Medicine and Biomedical Sciences, College Station, Texas 77843, USA
George Stoica
Affiliation:
Department of Veterinary Pathobiology and the Schubot Exotic Bird Health Center, Texas A&M University, College of Veterinary Medicine and Biomedical Sciences, College Station, Texas 77843, USA
Susan Payne
Affiliation:
Department of Veterinary Pathobiology and the Schubot Exotic Bird Health Center, Texas A&M University, College of Veterinary Medicine and Biomedical Sciences, College Station, Texas 77843, USA
*
*Corresponding author. E-mail: itizard@cvm.tamu.edu
Rights & Permissions [Opens in a new window]

Abstract

Natural bornavirus infections and their resulting diseases are largely restricted to horses and sheep in Central Europe. The disease also occurs naturally in cats, and can be induced experimentally in laboratory rodents and numerous other mammals. Borna disease virus-1 (BoDV-1), the cause of most cases of mammalian Borna disease, is a negative-stranded RNA virus that replicates within the nucleus of target cells. It causes severe, often lethal, encephalitis in susceptible species. Recent events, especially the discovery of numerous new species of bornaviruses in birds and a report of an acute, lethal bornaviral encephalitis in humans, apparently acquired from squirrels, have revived interest in this remarkable family of viruses. The clinical manifestations of the bornaviral diseases are highly variable. Thus, in addition to acute lethal encephalitis, they can cause persistent neurologic disease associated with diverse behavioral changes. They also cause a severe retinitis resulting in blindness. In this review, we discuss both the pathological lesions observed in mammalian bornaviral disease and the complex pathogenesis of the neurologic disease. Thus infected neurons may be destroyed by T-cell-mediated cytotoxicity. They may die as a result of excessive inflammatory cytokine release from microglia. They may also die as a result of a ‘glutaminergic storm’ due to a failure of infected astrocytes to regulate brain glutamate levels.

Information

Type
Review Article
Copyright
Copyright © Cambridge University Press 2016 
Figure 0

Fig. 1. The intranuclear replication of bornaviruses. The viral ribonucleoprotein (RNP) complex is imported into the nucleus. It binds to the nuclear chromatin and generates more of these RNP complexes. The virus rarely forms complete virions and as a result, it probably spreads between cells in the form of the RNP.

Figure 1

Fig. 2. The major sites within the equine brain that BoDV-1 appears to favor. Infected neurons are also scattered diffusely throughout the cerebrum. The arrows indicate what is believed to be the ‘natural’ route of viral invasion, originating in the olfactory bulb.

Figure 2

Fig. 3. A schematic diagram showing the multiple alterations in neurogenesis induced by BoDV-1 in neonatal mice.

Figure 3

Fig. 4. The three major mechanisms of neuronal destruction mediated by BoDV-1. These are, T-cell-mediated cytotoxicity, microglial activation resulting in cytokine-mediated neurotoxicity, and loss of astrocyte function resulting in glutamate accumulation and excitotoxic destructions of neurons.

Figure 4

Fig. 5. The role of microglial activation in the pathogenesis of bornaviral encephalitis. M1 activation of the microglia results in the flooding of the brain with multiple cytokines as well as potent oxidants resulting in neuronal death. Should the microglial phenotype change to M2, the resulting cytokines will reduce inflammation and cell destruction and promote repair although destroyed neurons unlikely to be replaced.

Figure 5

Fig. 6. The role of glutamate in BoDV-1 encephalitis. The normal glutamate cycle requires that astrocytes remove excess glutamate from the extracellular fluid, convert it to glutamine and return it to the neurons. If astrocytes are damaged glutamate accumulates and kills neurons. GABAergic neurons release GABA that inhibits glutamate excitotoxicity and microglial activation. If these neurons are also damaged by BoDV-1 then additional neuronal loss will be expected.